PARSABIV FDA approval date
The FDA approved PARSABIV on 7 Feb 2017.
- FDA approval date
- 7 Feb 2017
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as ETELCALCETIDE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2017-02-07Day | PARSABIV | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208325", "applicant_as_listed_by_fda": "KAI PHARMS INC", "brand_names": ["PARSABIV"], "active_ingredients": ["ETELCALCETIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170207", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |